Belyntic Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $6.5M

Belyntic General Information

Description

Developer of peptide-based immunotherapies designed to treat and prevent infectious diseases and cancer. The company develops synthetic long peptide-based vaccines using a modular platform to induce targeted T-cell immune responses and integrates AI-based prediction tools, enabling biotechnology and pharmaceutical partners to develop therapeutic and prophylactic vaccine candidates.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Scharnhorststr. 24
  • 10115 Berlin
  • Germany
+49 030
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • Scharnhorststr. 24
  • 10115 Berlin
  • Germany
+49 030

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Belyntic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 17-Nov-2022 $6.5M Completed Generating Revenue
6. Accelerator/Incubator Completed Pre-Clinical Trials
5. Accelerator/Incubator Completed Pre-Clinical Trials
4. Later Stage VC 01-Dec-2021 Completed Pre-Clinical Trials
3. Grant 30-Nov-2020 Completed Pre-Clinical Trials
2. Seed Round 01-May-2019 $1.46M $1.46M Completed Pre-Clinical Trials
1. Grant 01-Sep-2016 $896K Completed Startup
To view Belyntic’s complete valuation and funding history, request access »

Belyntic Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of peptide-based immunotherapies designed to treat and prevent infectious diseases and cancer. The company dev
Drug Discovery
Berlin, Germany
2 As of 2026

San Diego, CA
 

Watertown, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Belyntic Competitors (28)

One of Belyntic’s 28 competitors is BPS Bioscience, a Corporation company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BPS Bioscience Corporation San Diego, CA
Selecta Biosciences Formerly VC-backed Watertown, MA
Barinthus Biotherapeutics Formerly VC-backed Altrincham, United Kingdom
AsherBio Venture Capital-Backed South San Francisco, CA
VBI Vaccines Corporation Cambridge, MA
You’re viewing 5 of 28 competitors. Get the full list »

Belyntic Patents

Belyntic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021023892-A1 A method for modification of peptides immobilized on a solid support by traceless reductively cleavable linker molecules Inactive 07-Aug-2019
US-12473328-B2 Method for modification of peptides immobilized on a solid support by traceless reductively cleavable linker molecules Active 07-Aug-2019
EP-3666752-A1 Traceless reductively cleavable linker molecules for peptide purification Inactive 13-Dec-2018
WO-2020043747-A1 Traceless reductively cleavable linker molecules for peptide purification Inactive 27-Aug-2018
EP-3408257-B1 Linker molecule and use of it in process for purification of peptides Active 29-Jan-2016 C07C317/28
To view Belyntic’s complete patent history, request access »

Belyntic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Belyntic Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Berlin Senate Department for Economics, Energy and Public Enterprises Government Minority
Exist Federal Ministry of Economics and Energy Government
High-Tech Gründerfonds Venture Capital Minority
Humboldt Innovation Accelerator/Incubator
Humboldt Tech Bridge Accelerator/Incubator
You’re viewing 5 of 7 investors. Get the full list »

Belyntic FAQs

  • When was Belyntic founded?

    Belyntic was founded in 2011.

  • Where is Belyntic headquartered?

    Belyntic is headquartered in Berlin, Germany.

  • What is the size of Belyntic?

    Belyntic has 2 total employees.

  • What industry is Belyntic in?

    Belyntic’s primary industry is Drug Discovery.

  • Is Belyntic a private or public company?

    Belyntic is a Private company.

  • What is the current valuation of Belyntic?

    The current valuation of Belyntic is .

  • What is Belyntic’s current revenue?

    The current revenue for Belyntic is .

  • How much funding has Belyntic raised over time?

    Belyntic has raised $2.6M.

  • Who are Belyntic’s investors?

    Berlin Senate Department for Economics, Energy and Public Enterprises, Exist Federal Ministry of Economics and Energy, High-Tech Gründerfonds, Humboldt Innovation, and Humboldt Tech Bridge are 5 of 7 investors who have invested in Belyntic.

  • Who are Belyntic’s competitors?

    BPS Bioscience, Selecta Biosciences, Barinthus Biotherapeutics, AsherBio, and VBI Vaccines are some of the 28 competitors of Belyntic.

  • When was Belyntic acquired?

    Belyntic was acquired on 17-Nov-2022.

  • Who acquired Belyntic?

    Belyntic was acquired by Mesa Labs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process